Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients
The move follows a similar price cut by Eli Lilly as both GLP-1 drugmakers attempt to fend off cheaper compounded versions of their popular obesity meds.
The move follows a similar price cut by Eli Lilly as both GLP-1 drugmakers attempt to fend off cheaper compounded versions of their popular obesity meds.
